TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03162484

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: The program includes different activities: swimming, paddle tennis, football and aerobic exercises into the swimming-pool.
Study: NCT03645694

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Social Support Aid
Description: Please see earlier; the social support aid technology consists of a smartphone with a facial recognition software application and a smartwatch. Up to 1,000 individuals can be enrolled in the facial recognition application. Enrollment includes typing individuals names and relationships of the person with memory concern into the application and taking pictures of PWMC's faces at multiple angles. Once enrolled and in view of the smartphone's camera, the SSA's application recognizes the individual's face and alerts the smartwatch. The watch then vibrates and displays the individuals' name and relationship to the PWMC.
Study: NCT03913832

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: sirolimus drug coated balloon (SCB)
Description: Magic TouchTM (Concept Medical) is a sirolimus drug coated balloon (SCB) for PCI, based on a polymer-free and Nano based drug delivery technology. Magic Touch SCB is a product of CMI proprietary drug delivery technology Nanolute. It is indicated (CE approved) for ISR, small vessels, bifurcation lesions \& de novo lesions.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel releasing coronary balloon catheter
Description: SeQuent PleaseTM (B. Braun Melsungen AG, Vascular Systems,Berlin, Germany) is a paclitaxel releasing coronary balloon catheter.
Study: NCT04481750

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-1186-matching placebo
Description: Solution or suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-1186-matching placebo
Description: Solution or suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-1186-matching placebo
Description: Solution or suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-1186-matching placebo
Description: Solution or suspension

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-1186-matching placebo
Description: Solution or suspension
Study: NCT00384995

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.9% (154 mEq/L) IV Sodium Chloride
Description: Saline solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1/6 M (166 mEq/L) IV Sodium Bicarbonate
Description: Bicarbonate solution
Study: NCT00129454

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy
Description: The investigators adapted two previously validated CBT manuals for use in both Telephone and In-Person groups (the Personal Health Improvement Program and Dr. Charles Engel's group treatment for GWI). Treatment included the following standard components of CBT: Didactic or educational material about the causes of GWI and an explanation of how thinking can cause stress (ABC model); Assessment of psychological distress and behavioral problems that may be targets of therapeutic intervention (e.g. symptom-related anxiety); Assessment of thinking errors that lead to psychological distress and trigger behavioral problems (e.g. catastrophizing); Cognitive restructuring to teach disputing skills or how to correct thinking errors; Cognitive and behavioral homework assignments (e.g. written self-disclosure); Didactic homework assignments (e.g. listen to previous treatment session).
Study: NCT02992951

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DACC-Coated Post Operative Dressing
Description: Leukomed Sorbact is a non-active coated wound dressing, containing Dialkylcarbomoylchloride. This is a bacteria-binding compound that adheres bacteria via hydrophobic interaction and removes them from the wound bed at dressing change.
Study: NCT00129454

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: The investigators adapted two previously validated CBT manuals for use in both Telephone and In-Person groups (the Personal Health Improvement Program and Dr. Charles Engel's group treatment for GWI). Treatment included the following standard components of CBT: Didactic or educational material about the causes of GWI and an explanation of how thinking can cause stress (ABC model); Assessment of psychological distress and behavioral problems that may be targets of therapeutic intervention (e.g. symptom-related anxiety); Assessment of thinking errors that lead to psychological distress and trigger behavioral problems (e.g. catastrophizing); Cognitive restructuring to teach disputing skills or how to correct thinking errors; Cognitive and behavioral homework assignments (e.g. written self-disclosure); Didactic homework assignments (e.g. listen to previous treatment session).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy
Description: This description is the same as the experimental treatment only disseminated in person rather than over the telephone.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: This description is the same as the experimental treatment only disseminated in person rather than over the telephone.
Study: NCT03520231

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: RANK Ligand Inhibitor

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Denosumab Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemcitabine
Description: Antineoplastic Agent

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Antineoplastic Agent

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: Antineoplastic Agent

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Antineoplastic Agent

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin
Description: Antineoplastic Agent
Study: NCT01546441

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interprofessional assessment
Description: assessment by interprofessional team

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: usual care
Description: usual care in primary care clinic
Study: NCT03520231

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Antineoplastic Agent

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Calcium
Description: Calcium Supplement

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Calcium
Description: Calcium Supplement

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D
Description: Vitamin D Supplement
Study: NCT02912247

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: adalimumab
Description: adalimumab, 40mg,subcutaneous injection,once
Study: NCT04317430

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Niclosamide
Description: Niclosamide tablets 1 gram once daily
Study: NCT03381482

Intervention type: DIAGNOSTIC_TEST
Intervention: CSF drawing during spinal anaesthesia
Description: 4mL of CSF by lumbar puncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Fasting blood sample
Description: 6x5 mL of fasting blood sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Fasting blood sample
Description: 6x5 mL of fasting blood sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Fasting blood sample
Description: 6x5 mL of fasting blood sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Fasting blood sample
Description: 6x5 mL of fasting blood sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Fasting blood sample
Description: 6x5 mL of fasting blood sample

Intervention type: DIAGNOSTIC_TEST
Intervention: Lumbar puncture
Description: 10 mL of CSF by lumbar puncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Lumbar puncture
Description: 10 mL of CSF by lumbar puncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Lumbar puncture
Description: 10 mL of CSF by lumbar puncture

Intervention type: DIAGNOSTIC_TEST
Intervention: Lumbar puncture
Description: 10 mL of CSF by lumbar puncture
Study: NCT03255213

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lingual Muscle Training
Description: Lingual Muscle Training using the Iowa Oral Performance Instrument (OIPI) device
Study: NCT04201366

Intervention type: OTHER
Intervention: No intervention
Description: No intervention

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT00043108

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional surgery

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Study: NCT03600766

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mirabegron
Description: oral mirabegron 50 gm plus tamsulosin 0.4 mg once daily for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: oral toltordine 4 mg plus tamsulosin 0.4 mg daily for 8 weeks.
Study: NCT02509039

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-122
Description: 5 continuous days out of 7 days per week intermittent dosing
Study: NCT02089464

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NBS-guided rTMS

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Task oriented rehabilitation

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Task oriented rehabilitation
Study: NCT03103204

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth disinfection with chlorhexidine
Description: Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons).~Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel).~Oral hygiene instructions will be given for all participants.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth disinfection with chlorhexidine
Description: Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons).~Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel).~Oral hygiene instructions will be given for all participants.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth disinfection with chlorhexidine
Description: Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons).~Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel).~Oral hygiene instructions will be given for all participants.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth disinfection with chlorhexidine
Description: Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons).~Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel).~Oral hygiene instructions will be given for all participants.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth disinfection with chlorhexidine
Description: Mechanical procedures, composed of full-mouth dental scaling and root planning and dental prophylaxis, will be completed within 24 hours (2 appointments in 2 consecutive mornings or afternoons).~Chlorhexidine will be used as the antimicrobial agent in different concentrations (0.2%, 1% and 2%) and vehicles (solution, gel).~Oral hygiene instructions will be given for all participants.
Study: NCT03943550

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7049665
Description: Multiple ascending doses of RO7049665 will be administered SC.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo will be administered SC.
Study: NCT03180437

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IRE surgery
Description: IRE surgery will be used in local tumor

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IRE plus γδ T cells
Description: Combination IRE surgery and γδ T cell will be used in Pancreatic Cancer
Study: NCT03520231

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Vitamin D Supplement
Study: NCT01681732

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized Care Plan
Description: We will develop a personalized plan based on info collected in the primary visit

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Standard Care
Description: This is the standard care arm
Study: NCT02614430

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vocational training
Description: The intervention consists of a physical training program, individual motivational talks and guidance on labor market-oriented topics. Each program is customised to the patient's physical resources and conditions where. The framework for the intervention of physical activity 1 hours 3 times weekly with concurrent motivational talks for an overall maximum duration of 9 weeks. Based on an assessment of the patient is instructed about pain management, ergonomics, conflict management, diet, lifestyle, behavior modification, stress symptoms and preventive home training.
Study: NCT02295150

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nadroparin
Description: Patients receive before surgery 3 days 2850 IU nadroparin. anti-Xa levels will be measured. After surgery they receive 5700 IU for 4 weeks as standard care in our hospital. 3 days and 4 weeks after surgery anti-Xa levels will be measured again.
Study: NCT03752190

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cosyntropin
Description: intramuscular and intravenous administration
Study: NCT04085510

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced mammogram
Description: Contrast-enhanced mammography (CEM) is a new FDA-approved exam that is similar to magnetic resonance imaging (MRI) in depicting breast cancers due to increased and leaky blood vessels. Contrast-enhanced mammography is used as an adjunct following mammography and/or ultrasound examinations to localize a known or suspected lesion.
Study: NCT01798173

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Serum, plasma and DNA samples

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Serum, plasma and DNA samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiological exploration by CT scan or MRI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiological exploration by CT scan or MRI
Study: NCT03904953

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates Training
Description: Clinical pilates exercises will be performed three days in a week. Treatment will continue an hour in per session for 8 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional exercise programme
Description: Stretching of erector spine, hip flexors, hamstring muscles and gastro-soleus muscles; back-strengthening of cervical, thoracic and lumbar spine and posture exercises will be taught to the patients in the first session and the patients will be requested to repeat the exercises three times a week for 8 weeks individually at home.
Study: NCT00536640

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: 80 mg/m2 i.v. on day 1 (three-week cycle) until tumor progression for a maximum of 6 cycles. (The administration of 40 mg/2 Cisplatin on day 1 and day 8 is also possible)
Study: NCT01933230

Intervention type: DEVICE
Group type: OTHER
Intervention: Excel Cryo Cooling System
Description: An Excel Cryo Cooling System collar will be place around the neck for two hours. This will cool the blood in the neck that goes to the brain causing the brain to become cool. The collar is a standard neck collar used for patients after neck surgery with a modification that allows for the placement of a cooling pack in the collar. The cooling pack is similar to the cooling packs used for sports injuries. The cooling packs will be changed every 20 minutes for the two-hour duration. During the study and for two hours after, we will collect data concerning the brain temperature, body temperature, brain oxygen level, and pressure both in the head and in the blood.~2 hour neck cooling period
Study: NCT00446472

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regranex®
Description: Regranex gel will be used for a total of 16 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrogel
Description: Placebo hydrogel will be applied for 16 weeks
Study: NCT04580758

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Fractional laser with PRP fluid or PRP gel
Description: 20 participants divided into 2 groups of 10 10 participants will do Fractional laser with PRP fluid sessions and 10 participants will do Fractional laser with PRP gel

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Fractional laser with PRP fluid or PRP gel
Description: 20 participants divided into 2 groups of 10 10 participants will do Fractional laser with PRP fluid sessions and 10 participants will do Fractional laser with PRP gel
Study: NCT02117895

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Celiac plexus resection
Description: Celiac plexus at the left side of aorta, between celiac trunk and superior mesenteric artery will be resected.
Study: NCT03147495

Intervention type: DIAGNOSTIC_TEST
Intervention: Standing anteroposterior knee radiographs and special proximal tibiofibular joint radiograph.
Description: Standing anteroposterior knee radiographs and special proximal tibiofibular joint radiographs will be taken for the participants in both groups. The standing anteroposterior knee radiographs will be obtained with the knee extended. The proximal tibiofibular joint radiographs will be acquired with the knee of the participants in approximately 45°-60° of internal rotation.
Study: NCT02117895

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreatectomy
Description: Standard distal pancreatectomy includes distal pancreatectomy, splenectomy, and regional lymph nodes resection for pancreatic cancer at the body and tail. Regional lymph nodes includes group 8, 10, 11, 18, 7, 9, 14, 15, according to the 2003 edition of lymph nodes group system defined by Japan Pancreas Society (JPS).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pancreatectomy
Description: Standard distal pancreatectomy includes distal pancreatectomy, splenectomy, and regional lymph nodes resection for pancreatic cancer at the body and tail. Regional lymph nodes includes group 8, 10, 11, 18, 7, 9, 14, 15, according to the 2003 edition of lymph nodes group system defined by Japan Pancreas Society (JPS).
Study: NCT03593135

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group)
Description: 15ml apple cider vinegar (American garden organic vinegar) (containing 5% acetic acid) mixed in 200ml water during meal at night time, for 3 months and tablet Tagipmet 50mg/1000mg (Metformin + Sitagliptin group) twice a day. NOTE medical treatment is our inclusion criteria.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Water with Apple Cider vinegar flavor and tablet Tagipmet (Metformin + Sitagliptin group)
Description: Flavor of apple cider vinegar in 200 ml water is added and given to have a placebo effect and tablet Tagipmet 50mg/1000mg (Metformin + Sitagliptin group) twice a day. NOTE medical treatment is our inclusion criteria.
Study: NCT00221715

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: femoropopliteal artery bypass
Description: Bypass by autologous saphenous vein

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: femoropopliteal artery bypass
Description: bypass by dacron or PTFE Prosthesis
Study: NCT01552616

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thermal-aided muscle activation
Description: Thermal-aided muscle activation therapy will be provided to patients twice daily. Treatment will begin within 24 hours of admission and continue until patients are significantly ambulatory.
Study: NCT02980146

Intervention type: OTHER
Intervention: Non interventional study
Study: NCT01094353

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mini-sling
Description: The minisling is a new intervention therapeutic option for surgical treatment in women with stress urinary incontinence. It is made of polypropylene monofilament mesh, held between two self-anchoring polypropylene columns in a fishbone design connected to two delivering needles.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transobturator
Description: Transobturator sling Unitape™ is an outside-in approach therapeutic option for surgical treatment in women with stress urinary incontinence
Study: NCT04421872

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: receiving general anesthesia
Description: patients receiving surgery under general anesthesia
Study: NCT01810068

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Holmium laser enucleation of the prostate
Description: Laser assisted enucleation of the prostatic adenoma

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Monopolar transurethral resection of the prostate
Description: using the monopolar electrocautery to resect the prostate adenoma

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar transurethral resection of the prostate
Description: using the bipolar electrocautery to resect the prostate adenoma

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Diagnostic cystoscopy
Description: Cysto-urethroscopy
Study: NCT03569891

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: AAV5-hFIXco-Padua
Description: Single intravenous infusion of AAV5-hFIXco-Padua (AMT-061)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Factor IX (FIX)
Description: During the lead-in phase, which lasted for a minimum of 26 weeks (i.e., ≥6 months), subjects recorded their use of FIX replacement therapy and bleeding episodes in their dedicated e-diary.